NCT06937125 Evaluation of Valvular Heart Disease Using Cardiac CT
| NCT ID | NCT06937125 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Toho University |
| Condition | Valvular Heart Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 350 participants |
| Start Date | 2025-03-12 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 350 participants in total. It began in 2025-03-12 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The EVIDENTIA Registry is a multicenter study designed to evaluate valvular heart disease (VHD) using cardiac CT. It aims to assess cardiac valve anatomy, function, and myocardial characteristics through detailed CT analysis. 1. Assessing the accuracy of cardiac CT in evaluating cardiac structure, volume, function, and myocardium in VHD patients. 2. Comparing the severity, classification, and etiology (primary vs. functional) of VHD. 3. Monitoring serial changes in VHD severity via echocardiography. 4. Investigating the relationship between echocardiographic and CT-derived parameters. 5. Examining the correlation between imaging findings, VHD interventions, and patient prognosis.
Eligibility Criteria
Inclusion Criteria: * Patients with at least moderate valvular heart disease who had a cardiac CT with 64 or more rows * 18 years of age or older Exclusion Criteria: * Less than 18 years old * Acute VHD * Infectious endocarditis * Patients with post-VHD intervention * Poor CT image quality for analyzing CT data.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06937125 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Valvular Heart Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06937125 currently recruiting?
Yes, NCT06937125 is actively recruiting participants. Contact the research team at hideki.koike@med.toho-u.ac.jp for enrollment information.
Where is the NCT06937125 trial being conducted?
This trial is being conducted at Ōta-ku, Japan.
Who is sponsoring the NCT06937125 clinical trial?
NCT06937125 is sponsored by Toho University. The trial plans to enroll 350 participants.